Skip to Content

M V23 (Hydrochlorothiazide and Valsartan 25 mg / 160 mg)

Pill with imprint M V23 is Orange, Elliptical / Oval and has been identified as Hydrochlorothiazide and Valsartan 25 mg / 160 mg. It is supplied by Mylan Pharmaceuticals Inc..

Hydrochlorothiazide/valsartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/valsartan 25 mg / 160 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M V23

Hydrochlorothiazide and valsartan 25 mg / 160 mg M V23
Hydrochlorothiazide and valsartan 25 mg / 160 mg M V23
Hydrochlorothiazide and valsartan 25 mg / 160 mg M V23

Hydrochlorothiazide and Valsartan

Imprint
M V23
Strength
25 mg / 160 mg
Color
Orange
Size
15.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Angiotensin ii inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, hypromelloses, ferric oxide red, lactose monohydrate, magnesium stearate, ferric oxide yellow, microcrystalline cellulose, polydextrose, polyethylene glycol, povidone, corn starch, sodium lauryl sulfate, triacetin, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-6323 Mylan Pharmaceuticals Inc.
51079-0194 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.